Hasan Akbaba
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 15
- Advanced biosensing and bioanalysis techniques 4
- Lipid Membrane Structure and Behavior 4
-
- Advancements in Transdermal Drug Delivery 5
- Co-authors
- Gülşah Erel‐Akbaba (18 shared papers)Ayşe Gülten Kantarcı (8 shared papers)Mustafa Kotmakçı (5 shared papers)Yücel Başpınar (7 shared papers)Ralph Weissleder (1 shared paper)Tian Tian (2 shared papers)Litia Carvalho (1 shared paper)Bakhos A. Tannous (2 shared papers)
- Journals
- Journal of Drug Delivery Science and Technology (3 papers)International Journal of Pharmaceutics (2 papers)ACS Omega (2 papers)European Journal of Medicinal Chemistry (1 paper)Scientific Reports (1 paper)
- Partner nations
- TürkiyeUnited StatesGermany
In The Last Decade
Hasan Akbaba
32 papers receiving 552 citations
Peers
Comparison fields: 5 of 77
- Biomaterials 170
- Pharmaceutical Science 74
- Immunology 106
- Molecular Medicine 18
- Biomedical Engineering 157
Countries citing papers authored by Hasan Akbaba
This map shows the geographic impact of Hasan Akbaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Akbaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Akbaba more than expected).
Fields of papers citing papers by Hasan Akbaba
This network shows the impact of papers produced by Hasan Akbaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Akbaba. The network helps show where Hasan Akbaba may publish in the future.
Co-authors
The 25 scholars most cited alongside Hasan Akbaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 173 | |
| 2 | 2020 | 71 | |
| 3 | 2016 | 56 | |
| 4 | 2016 | 32 | |
| 5 | 2020 | 26 | |
| 6 | 2019 | 26 | |
| 7 | 2020 | 23 | |
| 8 | 2018 | 16 | |
| 9 | 2016 | 13 | |
| 10 | 1997 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2018 | 10 | |
| 13 | 2021 | 10 | |
| 14 | 2022 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2018 | 7 | |
| 19 | 2020 | 6 | |
| 20 | 2019 | 5 |
About Hasan Akbaba
Hasan Akbaba is a scholar working on Molecular Biology, Pharmaceutical Science, Immunology, Biomedical Engineering and Organic Chemistry, having authored 34 papers that have together received 556 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (6 papers), Advancements in Transdermal Drug Delivery (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), Lipid Membrane Structure and Behavior (4 papers), Toxin Mechanisms and Immunotoxins (3 papers), Immunotherapy and Immune Responses (3 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Biomaterials (170 citations), Pharmaceutical Science (74 citations), Immunology (106 citations), Molecular Medicine (18 citations) and Biomedical Engineering (157 citations). Hasan Akbaba has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Gülşah Erel‐Akbaba, Ayşe Gülten Kantarcı, Mustafa Kotmakçı, Yücel Başpınar, Ralph Weissleder, Tian Tian, Litia Carvalho, Bakhos A. Tannous, Max Zinter and E. Antonio Chiocca. Their work appears in journals such as Journal of Drug Delivery Science and Technology, International Journal of Pharmaceutics, ACS Omega, European Journal of Medicinal Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.